反応式
Cl.[NH2:2][C@H:3]([C:5]([NH2:7])=[O:6])[CH3:4].O=[C:9]([CH3:17])[CH2:10][CH2:11][C:12](OCC)=[O:13]>O>[CH3:4][C@@H:3]1[N:2]2[C:12](=[O:13])[CH2:11][CH2:10][C:9]2([CH3:17])[NH:7][C:5]1=[O:6]参加物
4
実験手順
L-Alaninamide hydrochloride (20.7 g, 0.166 mol) and ethyl 4-oxopentanoate (20 g, 0.13 mol) were reacted together according to the procedure of Example 2 to give the title compound, 4.5 g (19.1%), m.p. 228°-230° (with decomposition), [alpha]D =+50.7° (c=3, H2O). NMR (CDCl3): deltaH =7.95 (bs, 1H, NH); 4.30 (q, J=8 Hz, 1H, CHCH3); 3.00-2.10 (c.a., 4H, CH2CH2); 1.60 (s, 3H, C-CH3 ; 1.45 (d, J=8 Hz, 3H, CH3CH). MS (E.I., 70 eV, 1.5 mA) m/z=168 (M+), 153 (M-CH3)+, 125 (M-CHNO)+, 112 (M-C3H4O)+.
出典と根拠
- ORDレコード
- ord-3236ab67972b4598a46b612d816c066b
- 出典データセット
- uspto-grants-1993_04
- 特許番号
- US05200406
関連ノート
読み込み中…